Medicina
Facultad
Fundación Hipercolesterolemia Familiar
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Hipercolesterolemia Familiar (35)
2024
-
Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia: A multi-national study
American Journal of Preventive Cardiology, Vol. 17
-
Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study
Circulation. Cardiovascular imaging, Vol. 17, Núm. 1, pp. e016206
-
Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients
Atherosclerosis, Vol. 392
2023
-
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
Circulation, Vol. 147, Núm. 19, pp. 1436-1443
-
Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study
European journal of preventive cardiology, Vol. 30, Núm. 4, pp. 320-328
-
Response by Pérez de Isla et al to Letter Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study"
Circulation
2022
-
A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort
European Journal of Preventive Cardiology, Vol. 29, Núm. 5, pp. 795-801
-
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients
Journal of Clinical Lipidology, Vol. 16, Núm. 5, pp. 733-736
-
Relationship between the coronary artery calcium quantification and gut microbiota composition in subjects without previous cardiovascular disease: A pilot study
Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 4, pp. 205-215
2021
-
Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study
Atherosclerosis, Vol. 317, pp. 52-58
-
Dyslipidemia and aortic valve disease
Current opinion in lipidology, Vol. 32, Núm. 6, pp. 349-354
-
Lipoprotein(a), LDL-cholesterol, and hypertension: Predictors of the need for aortic valve replacement in familial hypercholesterolaemia
European Heart Journal, Vol. 42, Núm. 22, pp. 2201-2211
-
The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia
JACC: Cardiovascular Imaging, Vol. 14, Núm. 12, pp. 2414-2424
2020
-
Heart failure and diabetes, opportunities for improving treatment through patient characterisation
Revista Clinica Espanola
-
Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry
Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 828-834
2019
-
Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients with Familial Hypercholesterolemia: A Computed Tomographic Angiography Imaging Study
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 39, Núm. 5, pp. 945-955
-
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study
Journal of Clinical Lipidology, Vol. 13, Núm. 6, pp. 989-996
-
Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia
Atherosclerosis, Vol. 286, pp. 40-45
-
VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia
Atherosclerosis, Vol. 285, pp. 17-22
-
Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia
Journal of the American College of Cardiology, Vol. 73, Núm. 9, pp. 1029-1039